Development and validation of bioanalytical method for the detection of gliclazide in human plasma

A robust High Performance Liquid Chromatography Diod Array Detection (HPLC- DAD) method was developed for the detection of gliclazide in human plasma. Liquid liquid extraction method was used as a sample preparation for HPLC analysis. The separation was carried out on Agilent Zorbax Reversed P...

Full description

Bibliographic Details
Main Authors: Alaama, Mohamed, Helaluddin, Abul Bashar Mohammed, Izat, I'zma, Kamarbashrudin, Siti Khadijah Rose
Format: Conference or Workshop Item
Language:English
Published: 2016
Subjects:
Online Access:http://irep.iium.edu.my/55423/
http://irep.iium.edu.my/55423/1/Development%20and%20Validation%20of%20Bioanalytical%20Method%20for%20the%20Detection.pdf
id iium-55423
recordtype eprints
spelling iium-554232017-03-02T01:44:05Z http://irep.iium.edu.my/55423/ Development and validation of bioanalytical method for the detection of gliclazide in human plasma Alaama, Mohamed Helaluddin, Abul Bashar Mohammed Izat, I'zma Kamarbashrudin, Siti Khadijah Rose QD Chemistry R Medicine (General) RS Pharmacy and materia medica A robust High Performance Liquid Chromatography Diod Array Detection (HPLC- DAD) method was developed for the detection of gliclazide in human plasma. Liquid liquid extraction method was used as a sample preparation for HPLC analysis. The separation was carried out on Agilent Zorbax Reversed Phase C-18 column (150 x 4.6 mm, 5µ m) with PDA detection at 236 nm. with an isocratic elution (1 mL/min) at 30°C column temperature. The mobile phases used consisted of acetonitrile: 0.3% triethylamine buffer (pH=3.0 adjusted with H3PO4 85%) 57:43 v/v. Then, 10 µL aliquot samples were injected onto chromatographic system. The results showed that the retention time for the gliclazide and the internal standard, glibenclamide were 3.8 and 4.8 respectively. The method was linear over the range of 10 – 5000 ppb with R2 of 0.9971. The recoveries of the developed methods for gliclazide were found to be between 84.9% and 104.0%, while for the glibenclamide were found to be between 100.0% and 112.0%. The stability analysis showed that gliclazide is stable for at least 3 months but glibenclamide is degraded for about 2 months when stored at -20 ?. For conclusion, the develop method is suitable and reliable for the detection of gliclazide in human plasma. 2016 Conference or Workshop Item NonPeerReviewed application/pdf en http://irep.iium.edu.my/55423/1/Development%20and%20Validation%20of%20Bioanalytical%20Method%20for%20the%20Detection.pdf Alaama, Mohamed and Helaluddin, Abul Bashar Mohammed and Izat, I'zma and Kamarbashrudin, Siti Khadijah Rose (2016) Development and validation of bioanalytical method for the detection of gliclazide in human plasma. In: 2nd International Conference on Industrial Pharmacy (2nd ICIP 2016), 15th-16th Aug. 2016, Kuantan, Pahang. (Unpublished)
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic QD Chemistry
R Medicine (General)
RS Pharmacy and materia medica
spellingShingle QD Chemistry
R Medicine (General)
RS Pharmacy and materia medica
Alaama, Mohamed
Helaluddin, Abul Bashar Mohammed
Izat, I'zma
Kamarbashrudin, Siti Khadijah Rose
Development and validation of bioanalytical method for the detection of gliclazide in human plasma
description A robust High Performance Liquid Chromatography Diod Array Detection (HPLC- DAD) method was developed for the detection of gliclazide in human plasma. Liquid liquid extraction method was used as a sample preparation for HPLC analysis. The separation was carried out on Agilent Zorbax Reversed Phase C-18 column (150 x 4.6 mm, 5µ m) with PDA detection at 236 nm. with an isocratic elution (1 mL/min) at 30°C column temperature. The mobile phases used consisted of acetonitrile: 0.3% triethylamine buffer (pH=3.0 adjusted with H3PO4 85%) 57:43 v/v. Then, 10 µL aliquot samples were injected onto chromatographic system. The results showed that the retention time for the gliclazide and the internal standard, glibenclamide were 3.8 and 4.8 respectively. The method was linear over the range of 10 – 5000 ppb with R2 of 0.9971. The recoveries of the developed methods for gliclazide were found to be between 84.9% and 104.0%, while for the glibenclamide were found to be between 100.0% and 112.0%. The stability analysis showed that gliclazide is stable for at least 3 months but glibenclamide is degraded for about 2 months when stored at -20 ?. For conclusion, the develop method is suitable and reliable for the detection of gliclazide in human plasma.
format Conference or Workshop Item
author Alaama, Mohamed
Helaluddin, Abul Bashar Mohammed
Izat, I'zma
Kamarbashrudin, Siti Khadijah Rose
author_facet Alaama, Mohamed
Helaluddin, Abul Bashar Mohammed
Izat, I'zma
Kamarbashrudin, Siti Khadijah Rose
author_sort Alaama, Mohamed
title Development and validation of bioanalytical method for the detection of gliclazide in human plasma
title_short Development and validation of bioanalytical method for the detection of gliclazide in human plasma
title_full Development and validation of bioanalytical method for the detection of gliclazide in human plasma
title_fullStr Development and validation of bioanalytical method for the detection of gliclazide in human plasma
title_full_unstemmed Development and validation of bioanalytical method for the detection of gliclazide in human plasma
title_sort development and validation of bioanalytical method for the detection of gliclazide in human plasma
publishDate 2016
url http://irep.iium.edu.my/55423/
http://irep.iium.edu.my/55423/1/Development%20and%20Validation%20of%20Bioanalytical%20Method%20for%20the%20Detection.pdf
first_indexed 2023-09-18T21:18:20Z
last_indexed 2023-09-18T21:18:20Z
_version_ 1777411713531904000